Browsing Tag
weight loss drug
5 posts
Structure Therapeutics (Nasdaq: GPCR) posts 16% weight loss with oral GLP-1 drug aleniglipron, setting up Phase 3 push
Structure Therapeutics' aleniglipron hits 16% weight loss at 44 weeks in Phase 2, matching injectables. Read the full analysis before Phase 3 begins.
Can Dr. Reddy’s GLP-1 strategy position it as a key player in the global metabolic drug race?
Explore Dr. Reddy’s GLP‑1 pipeline, patent strategy, and emerging market focus—can the Hyderabad-based pharma firm lead India’s metabolic drug push?
Metabolics Pharma’s ENT-03 shows promising Phase 1a data in obese and type 2 diabetic patients at ADA 2025
Metabolics Pharma’s ENT-03 shows Phase 1a success in obese and diabetic subjects, with plans for Phase 1b in late 2025. Learn about its brain-based mechanism.
Scientists identify drug for obese people to lose weight by reducing appetite
Good news for all the obese people who want to lose weight as scientists found a new drug…
Weight loss drug, lorcaserin found to solve opiate abuse
A recent research has found out that a weight loss drug given by prescription has the potential to…